Clinical Trials Browser

Phase 2/3 × Diarrhea × Breast × Clear all

NCT04736186 2021-02-03

Prevention and Treatment of Pyrrolitinib-associated Diarrhea

Phase 2/3 Unknown

Breast Neoplasms, Diarrhea